Skip to content

    agilon health (AGL) stock price & financials

    View AGL earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance32.9% YTD

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $1.45B
    $1.52B
    $0
    $513
    $1.44B
    -1.1%
    $1.57B
    +3.1%
    $442
    $521
    +1.6%
    Stable
    Operating Profit
    -$133.51M
    -$108.10M
    $0
    $26
    -$131.27M
    +1.7%
    -$193.82M
    -79.3%
    $1
    $6
    -76.9%
    Weakening
    Net Profit
    -$117.61M
    -$105.79M
    $0
    $12
    -$110.21M
    +6.3%
    -$188.88M
    -78.5%
    -$14
    $0
    -100.0%
    Weakening
    EPS
    $0.73
    $-6.31
    $-0.14
    -119.2%
    $0.00
    +100.0%
    Weakening
    Other Income
    $16.06M
    $7.70M
    $0
    $1
    $9.44M
    -41.2%
    $41.03M
    +433.3%
    $0
    $5
    +400.0%
    Strengthening
    Interest
    $1.62M
    $1.57M
    $0
    $8
    $1.84M
    +13.3%
    $1.72M
    +9.0%
    $7
    $6
    -25.0%
    Weakening
    Depreciation
    $0
    $3
    $3
    $3
    +0.0%
    Stable
    Profit before Tax
    -$117.02M
    -$104.67M
    $0
    $16
    -$110.54M
    +5.5%
    -$187.56M
    -79.2%
    -$9
    $2
    -87.5%
    Weakening
    MarginsOPM
    -9.2%
    -7.1%
    -1.4%
    5.1%
    -9.2%
    +0.5%
    -12.3%
    -73.9%
    0.2%
    1.1%
    -77.3%
    Weakening
    Tax
    0.5%
    -1.7%
    -11.6%
    25.0%
    0.3%
    -40.0%
    -0.7%
    +57.7%
    55.6%
    100.0%
    +300.0%
    Strengthening
    ReturnsROIC
    6.2%
    5.5%
    0.0%
    -0.0%
    5.8%
    -6.3%
    9.9%
    +78.5%
    0.0%
    0.0%
    +100.0%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$139.15M$106.80M$1.04B$465.30M$107.57M$188.23M$173.71M$107.18M
    Short-Term Investments$0$411.90M
    Total Current Assets$294.20M$1.37B$1.45B$1.48B$1.46B$1.10B$1.42B
    Net PP&E$6.46M$20.90M$31.95M$40.99M$36.95M$28.96M$29.39M
    Goodwill$41.54M$41.54M$2.51M$24.13M$24.13M$0
    Intangibles$60.47M$55.40M$18.45M$63.77M$72.77M$65.72M$60.13M
    Total Assets$446.36M$1.59B$1.70B$1.74B$1.73B$1.27B$1.59B
    LiabilitiesTotal Current Liabilities$266.83M$356.96M$535.09M$977.16M$1.15B$1.08B$1.31B
    Short-Term Debt$3.04M$5.00M$5.00M$6.25M$0$19.24M$14.91M
    Long-Term Debt$64.67M$43.40M$38.48M$32.31M$34.90M$15.75M$15.38M
    Long-Term Leases$5.51M$7.90M$9.09M$10.90M$6.60M$1.83M$3.15M
    Total Liabilities$421.59M$494.66M$656.86M$1.08B$1.26B$1.14B$1.36B
    EquityCommon Stock & APIC$2.49M$4.00M$4.12M$4.06M$4.12M$166.0K$168.0K
    Retained Earnings-$551.19M-$957.68M-$1.06B-$1.33B-$1.59B-$1.98B-$1.91B
    Total Equity-$232.03M-$284.73M$1.09B$1.04B$661.84M$470.95M$126.73M$227.53M
    HighlightsNet Cash / (Debt)$39.09M$991.64M$833.72M$69.01M$153.33M$138.72M$76.89M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$103.86M-$53.20M-$148.16M-$130.81M-$156.20M-$57.78M-$105.76M-$72.26M
    Cash from Investing-$5.06M$22.07M-$90.51M-$444.39M-$44.02M$139.89M$88.61M$80.42M
    Cash from Financing$176.30M$24.62M$1.15B$28.06M-$193.13M-$2.58M-$2.99M-$769.0K
    SummaryCapital Expenditure-$2.89M-$1.77M-$6.56M-$15.43M-$15.83M-$13.25M-$13.24M-$12.69M
    Free Cash Flow-$106.75M-$54.98M-$154.72M-$146.23M-$172.03M-$71.03M-$119.00M-$84.95M
    FCF Margin-13.4%-4.5%-10.2%-6.1%-4.0%-1.2%-2.0%-2.8%

    Ratios